Skip to content
io9

By

Reading time 1 minute

University of Michigan’s Risk Science Center offers a quick and handy explanation of the FDA’s recent crackdown on personal genomics company 23andme. Some clean, even-keeled perspective to be had here. For more, see these musings from genomics expert(and member of 23andme’s Scientific Advisory Board) Mike Eisen.

Explore more on these topics

Share this story

Sign up for our newsletters

Subscribe and interact with our community, get up to date with our customised Newsletters and much more.